Cresset, innovative provider of software and contract research services for small molecule discovery and design, signs three-way strategic agreement to speed up drug design.

Dr David Bardsley, Commercial Director, Cresset visited the School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China to sign a strategic cooperation agreement for drug design technology, developed within the Research Centre for Drug Discovery (RCDD)....

Fluid handling expert Diba Industries’ manufacturing facilities feature an ISO certified Class 7 / Fed Std Class 10,000 cleanroom to meet the needs of customers with high purity and particle-free assembly requirements.

The flexible 600 square foot space can be configured to accommodate a team of workers for high volume production of tubing assemblies, kits and integrated manifolds complete with valves, flow regulators and other controls....

Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building blocks in startling clarity and equips VARI’s growing team of scientists to push the limits of discovery in search of new treatments for diseases such as cancer and Parkinson’s.  

Cryo-electron microscopy (cryo-EM) is a revolutionary technique that reveals in unprecedented detail the molecular and atomic interactions at the foundation of life, allowing scientists to observe exactly how viruses enter cells, how DNA replicates, how chemical compounds assemble into functional biological components, and much more....

Universities of Leicester and Bristol lead new research into role statins play in lowering risk of venous thromboembolism

Further evidence has been found by Universities of Leicester and Bristol researchers to suggest statins could “significantly reduce” the occurrence of blood clotting in certain parts of the body. The research team analysed several studies previously carried out on the cholesterol-lowering pill and found the drug might have a potential role to play in lowering the recurring risk of venous thromboembolism (VTE)....

Chromatrap® has published a new article that describes a detailed genome wide comparison of native and crosslinked chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) using the company's patented solid state spin column technology.

Chromatrap® supply high quality N-ChIP-seq and X-ChIP-seq kits. This article compares the enrichment of the histone H3K4me3 modification signal across the whole genome, from chromatin prepared by both methods (native vs cross link). The histone mark H3K4me3 was chosen for this study to highlight the sensitivity and efficiency of the Chromatrap...

MEGA™ assay provides better insight for improved quality control testing

Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the implementation of MEGA™, a new mouse embryo assay that measures gene expression for quality control testing of raw materials used for the manufacture of media for in vitro fertilization (IVF)....

Funding from Deepbridge Capital, Innovate UK and Scottish Investment Bank will support development of next generation Ophthalmology biologics

Elasmogen Ltd, developer of soloMER^TM biologics, today announced that it has received a Biomedical Catalyst Grant from the UK’s innovation agency, Innovate UK and matching investment from Deepbridge Capital and Scottish Investment Bank (the investment arm of Scottish Enterprise) totalling £1.2 M....

Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project.

A new way of harnessing the sun’s rays to power ‘synthetic skin’ could help to create advanced prosthetic limbs capable of returning the sense of touch to amputees. 

Engineers from the University of Glasgow, who have previously developed an ‘electronic skin’ covering for prosthetic hands made from graphene, have found a way to use some of graphene’s remarkable physical properties to use energy from the sun to power the skin....

The University of Glasgow has officially opened its new £32M Imaging Centre of Excellence (ICE)

The unique medical research facility, which was built in collaboration with NHS Greater Glasgow and Clyde (NHSGGC) and with £16m funding from the Medical Research Council and Glasgow City Region City Deal, was opened by the Chief Executive Designate of UK Research and Innovation (UKRI), Professor Sir Mark Walport....

Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at the University of Warwick to rapidly and accurately analyse how Gram positive bacteria react to stressors.

This is providing information on phenotypic changes and may identify potential genetic targets, which could help in developing new anti-microbial therapies for drug-resistant bacteria. Researchers in the Department of Biomedical Sciences at the University of Warwick are using a G:BOX Chemi XX6 multi-application imaging system to study the changes...

Thermo Fisher honors Andrea Jacassi of the Italian Institute of Technology for image of cysteine crystals using focused ion beam techniques 

Italian Institute of Technology’s Andrea Jacassi is the grand prize winner of the Sixth Annual 2016 Thermo Fisher Scientific Electron Microscopy image contest for his “Cysteine Rose” image. The image, acquired using the FEI Helios NanoLab 650 DualBeam, focused ion beam/scanning electron microscope (FIB/SEM) and was selected by a vote of Thermo Fisher employees from more than 270 entries...

Compiling a list of chemists isn’t that difficult, just open a text book.

However, while we’re all aware of Marie Curie, Lois Pasteur and every Nobel Prize winner for chemistry, there are a large number of chemists who are changing the environment today, that you’ve probably never heard of. While you might not know their names, you certainly know their work....

The preparative and process chromatography market is expected to reach $8,950 million by 2019 from $6351.5 million in 2014, at a CAGR of 7.1%.

The global Preparative and Process Chromatography market is categorized on the basis of products and services, end user, and geography. The service segment is expected to register the highest growth rate in the Preparative and Process Chromatography market, by products and services, during the forecast period....

A first-ever ‘farm to fork’ programme for shrimp production has been announced, offering consumers DNA based assurance on the origin and quality of shrimp.

Through enhanced transparency the TraceBack programme will also help promote ethical labour practices, which have been highlighted in the global shrimp industry. The technology offering – already available in animal meat – has been developed by DNA tracing company IdentiGEN in partnership with international seafood producer Seafresh....

Investment will drive adoption of new diagnostic modality within healthcare system

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 million USD (£19.3 million GBP) since its spin-out from Owlstone Inc in 2016....

The market for chromatography resins is estimated to have accounted for USD 1.5 billion in 2014 and is projected to register a CAGR of 7.3% between 2015 and 2020, and reach the market size USD 2.3 billion by 2020.

Chromatography resins are polymers used as media in chromatographic techniques, namely, ion exchange, affinity, hydrophobic interaction, size exclusion, multi-modal and others (partition and adsorption). This report on chromatography resins market covers all major regions such as Asia-Pacific, Europe, North America, and Rest of the World....

Leading multinational life sciences tools and diagnostics developer - QuantuMDx has invested in the Asynt professional range of non-ducted laboratory filtration and fume cabinets which sit directly on benchtop surfaces.

QuantuMDx purchased the cabinets to aid the development of their portable diagnostic device Q-POC, which will provide sample-to-result diagnostic and drug susceptibility testing for a range of diseases in under 20 minutes by the patient’s side. The device is due for commercialisation in 2018....

Charnwood Campus and University of Leicester to inspire discovery, encourage collaboration and accelerate business growth for the Med-Tech and Biopharma community

Together with the site owners, Charnwood Campus, and the Leicester and Leicestershire Enterprise Partnership, the University of Leicester is seeking to establish a new Innovation Centre at the UK’s first ever Life Sciences Opportunity Zone in Charnwood, near Loughborough, to accelerate business growth for the Med-Tech and Biopharma community....

It lives inside one third of the UK population and is a common infection in cats, however until now scientists knew little about how the toxoplasmosis parasite communicated with its host.

New research, by the University of Glasgow’s Wellcome Centre for Molecular Parasitology in collaboration with The University of Vermont, has revealed how the parasite uses a key protein to form a communication network and ultimately continue the infection process....

Horizon Discovery Group plc has announced it has entered into a research and development collaboration and license agreement with AmplyCell S.A., to evaluate the impact of AmplyCell’s BOOST cell line optimisation technology on Horizon’s parental GS (glutamine synthetase) null CHO K1 cell line.

AmplyCell's Cell Fitness Technologies, which include BOOST, consist of a four-stage process to optimise cell lines in terms of stability and productivity. Cell lines can be stimulated using AmplyCell's Cell Fitness Technologies at any stage of cell line development or bioproduction (clone creation, RCB/DCB, MCB), without the need to change culture conditions.

Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment.

The announcement follows Eurofins’ acquisition of Exova’s pharmaceutical, food and water testing business in the UK & Ireland in July 2016, and the subsequent purchase of ILS’s pharmaceutical business in October 2016. Significantly increasing its capacity in the UK, the 5800 m² facility at Brucefield Industry Park will house Eurofins’ Biopharmaceutical Testing business in the UK...